Assembly Biosciences, Inc. reported earnings results for the full year ended December 31, 2023. For the full year, the company reported net loss was USD 61.23 million compared to USD 93.09 million a year ago. Basic loss per share from continuing operations was USD 13.38 compared to USD 23.08 a year ago.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
15.39 USD | +1.72% | +7.77% | +56.38% |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+56.38% | 84.85M | |
+19.36% | 79.99B | |
+15.93% | 9.25B | |
+42.06% | 4.45B | |
-22.01% | 4.43B | |
+8.28% | 4.03B | |
+11.22% | 2.24B | |
-26.61% | 2.18B | |
+11.64% | 2.02B | |
-42.69% | 1.79B |
- Stock Market
- Equities
- ASMB Stock
- News Assembly Biosciences, Inc.
- Assembly Biosciences, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023